Trenholme G H, Carson P E
JAMA. 1978 Nov 17;240(21):2293-5.
Physicians should be prepared to provide prophylactic medications for travelers to malarious areas and to treat patients with malaria. Chloroquine hydrochloride is the suppressive agent of choice for treatment of mild infections due to all species of malaria except for those due to chloroquine-resistant strains of Plasmodium falciparum. For treatment of severe infections with P falficparum, quinine is the suppressive agent of choice. Chloroquine is also the prophylactic agent of choice for most travelers. To prevent infection with P vivax or P ovale, primaquine must also be given. A RBC glucose-6-phosphate dehydrogenase level should be obtained before administration of primaquine. For prophylaxis of chloroquine-resistant strains of P falciparum, no completely satisfactory regimen is presently available in the United States.
医生应为前往疟疾流行地区的旅行者准备预防性药物,并治疗疟疾患者。盐酸氯喹是治疗除恶性疟原虫氯喹耐药菌株所致感染外的所有疟疾轻度感染的首选抑制性药物。对于恶性疟原虫严重感染的治疗,奎宁是首选抑制性药物。氯喹也是大多数旅行者的首选预防药物。为预防间日疟原虫或卵形疟原虫感染,还必须给予伯氨喹。在给予伯氨喹之前应检测红细胞葡萄糖-6-磷酸脱氢酶水平。对于预防恶性疟原虫氯喹耐药菌株,目前在美国尚无完全令人满意的方案。